Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)

SHA:688373 Revenue

Shanghai MicuRx Pharmaceutical had revenue of 42.06M CNY in the quarter ending March 31, 2026, with 26.62% growth. This brings the company's revenue in the last twelve months to 150.62M, up 15.44% year-over-year. In the year 2025, Shanghai MicuRx Pharmaceutical had annual revenue of 141.77M with 8.83% growth.

• Revenue (ttm): 150.62M
• Revenue Growth: +15.44%
• P/S Ratio: 22.05
• Revenue / Employee: 907.32K
• Employees: 166
• Market Cap: 3.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	141.77M	11.50M	8.83%
Dec 31, 2024	130.27M	39.50M	43.51%
Dec 31, 2023	90.78M	42.57M	88.31%
Dec 31, 2022	48.21M	40.55M	529.33%
Dec 31, 2021	7.66M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error